▶ 調査レポート

固形腫瘍検査の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Solid Tumor Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。固形腫瘍検査の世界市場2020年:企業別、地域別、種類・用途別 / Global Solid Tumor Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-00205資料のイメージです。• レポートコード:D0GIR-00205
• 出版社/出版日:GlobalInfoResearch / 2020年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、固形腫瘍検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。固形腫瘍検査の種類別市場規模(従来式検査、非従来式検査)、用途別市場規模(病院、診断研究所、学術研究機関)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):BD、Agilent Technologies、Danaher、F. Hoffmann-La Roche、Illumina、Thermo Fisher Scientific
・地域別グローバル市場分析 2015年-2020年
・固形腫瘍検査の北米市場(アメリカ、カナダ、メキシコ)
・固形腫瘍検査のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・固形腫瘍検査のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・固形腫瘍検査の南米市場(ブラジル、アルゼンチン)
・固形腫瘍検査の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:従来式検査、非従来式検査
・用途別分析:病院、診断研究所、学術研究機関
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Solid Tumor Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Solid Tumor Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Solid Tumor Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Solid Tumor Testing market has been segmented into:
Conventional Testing
Non-Conventional Testing

By Application, Solid Tumor Testing has been segmented into:
Hospitals
Diagnostic Laboratories
Academic and Research Institutes

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Solid Tumor Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Solid Tumor Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Solid Tumor Testing market.

The report offers in-depth assessment of the growth and other aspects of the Solid Tumor Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Solid Tumor Testing Market Share Analysis
Solid Tumor Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Solid Tumor Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Solid Tumor Testing sales, revenue and market share for each player covered in this report.

The major players covered in Solid Tumor Testing are:
BD
Agilent Technologies
Danaher
F. Hoffmann-La Roche
Illumina
Thermo Fisher Scientific

レポート目次

Table of Contents

1 Solid Tumor Testing Market Overview
1.1 Product Overview and Scope of Solid Tumor Testing
1.2 Classification of Solid Tumor Testing by Type
1.2.1 Global Solid Tumor Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Solid Tumor Testing Revenue Market Share by Type in 2019
1.2.3 Conventional Testing
1.2.4 Non-Conventional Testing
1.3 Global Solid Tumor Testing Market by Application
1.3.1 Overview: Global Solid Tumor Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Academic and Research Institutes
1.4 Global Solid Tumor Testing Market by Regions
1.4.1 Global Solid Tumor Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Solid Tumor Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Solid Tumor Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Solid Tumor Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Solid Tumor Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Solid Tumor Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Solid Tumor Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BD SWOT Analysis
2.1.4 BD Product and Services
2.1.5 BD Solid Tumor Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Agilent Technologies SWOT Analysis
2.2.4 Agilent Technologies Product and Services
2.2.5 Agilent Technologies Solid Tumor Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Danaher
2.3.1 Danaher Details
2.3.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Danaher SWOT Analysis
2.3.4 Danaher Product and Services
2.3.5 Danaher Solid Tumor Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche SWOT Analysis
2.4.4 F. Hoffmann-La Roche Product and Services
2.4.5 F. Hoffmann-La Roche Solid Tumor Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Illumina
2.5.1 Illumina Details
2.5.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Illumina SWOT Analysis
2.5.4 Illumina Product and Services
2.5.5 Illumina Solid Tumor Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Thermo Fisher Scientific
2.6.1 Thermo Fisher Scientific Details
2.6.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Thermo Fisher Scientific SWOT Analysis
2.6.4 Thermo Fisher Scientific Product and Services
2.6.5 Thermo Fisher Scientific Solid Tumor Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Solid Tumor Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Solid Tumor Testing Players Market Share
3.2.2 Top 10 Solid Tumor Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Solid Tumor Testing Revenue and Market Share by Regions
4.2 North America Solid Tumor Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Solid Tumor Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Solid Tumor Testing Revenue and Growth Rate (2015-2020)
4.5 South America Solid Tumor Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Solid Tumor Testing Revenue and Growth Rate (2015-2020)
5 North America Solid Tumor Testing Revenue by Countries
5.1 North America Solid Tumor Testing Revenue by Countries (2015-2020)
5.2 USA Solid Tumor Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Solid Tumor Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Solid Tumor Testing Revenue and Growth Rate (2015-2020)
6 Europe Solid Tumor Testing Revenue by Countries
6.1 Europe Solid Tumor Testing Revenue by Countries (2015-2020)
6.2 Germany Solid Tumor Testing Revenue and Growth Rate (2015-2020)
6.3 UK Solid Tumor Testing Revenue and Growth Rate (2015-2020)
6.4 France Solid Tumor Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Solid Tumor Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Solid Tumor Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Solid Tumor Testing Revenue by Countries
7.1 Asia-Pacific Solid Tumor Testing Revenue by Countries (2015-2020)
7.2 China Solid Tumor Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Solid Tumor Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Solid Tumor Testing Revenue and Growth Rate (2015-2020)
7.5 India Solid Tumor Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Solid Tumor Testing Revenue and Growth Rate (2015-2020)
8 South America Solid Tumor Testing Revenue by Countries
8.1 South America Solid Tumor Testing Revenue by Countries (2015-2020)
8.2 Brazil Solid Tumor Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Solid Tumor Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Solid Tumor Testing by Countries
9.1 Middle East & Africa Solid Tumor Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Solid Tumor Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Solid Tumor Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Solid Tumor Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Solid Tumor Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Solid Tumor Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Solid Tumor Testing Market Forecast by Type (2019-2024)
10.3 Conventional Testing Revenue Growth Rate (2015-2025)
10.4 Non-Conventional Testing Revenue Growth Rate (2015-2025)
11 Global Solid Tumor Testing Market Segment by Application
11.1 Global Solid Tumor Testing Revenue Market Share by Application (2015-2020)
11.2 Solid Tumor Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Academic and Research Institutes Revenue Growth (2015-2020)
12 Global Solid Tumor Testing Market Size Forecast (2021-2025)
12.1 Global Solid Tumor Testing Market Size Forecast (2021-2025)
12.2 Global Solid Tumor Testing Market Forecast by Regions (2021-2025)
12.3 North America Solid Tumor Testing Revenue Market Forecast (2021-2025)
12.4 Europe Solid Tumor Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Solid Tumor Testing Revenue Market Forecast (2021-2025)
12.6 South America Solid Tumor Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Solid Tumor Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Solid Tumor Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Solid Tumor Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Solid Tumor Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Solid Tumor Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. BD Corporate Information, Location and Competitors
Table 6. BD Solid Tumor Testing Major Business
Table 7. BD Solid Tumor Testing Total Revenue (USD Million) (2017-2018)
Table 8. BD SWOT Analysis
Table 9. BD Solid Tumor Testing Product and Solutions
Table 10. BD Solid Tumor Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Agilent Technologies Corporate Information, Location and Competitors
Table 12. Agilent Technologies Solid Tumor Testing Major Business
Table 13. Agilent Technologies Solid Tumor Testing Total Revenue (USD Million) (2018-2019)
Table 14. Agilent Technologies SWOT Analysis
Table 15. Agilent Technologies Solid Tumor Testing Product and Solutions
Table 16. Agilent Technologies Solid Tumor Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Danaher Corporate Information, Location and Competitors
Table 18. Danaher Solid Tumor Testing Major Business
Table 19. Danaher Solid Tumor Testing Total Revenue (USD Million) (2017-2018)
Table 20. Danaher SWOT Analysis
Table 21. Danaher Solid Tumor Testing Product and Solutions
Table 22. Danaher Solid Tumor Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 24. F. Hoffmann-La Roche Solid Tumor Testing Major Business
Table 25. F. Hoffmann-La Roche Solid Tumor Testing Total Revenue (USD Million) (2017-2018)
Table 26. F. Hoffmann-La Roche SWOT Analysis
Table 27. F. Hoffmann-La Roche Solid Tumor Testing Product and Solutions
Table 28. F. Hoffmann-La Roche Solid Tumor Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Illumina Corporate Information, Location and Competitors
Table 30. Illumina Solid Tumor Testing Major Business
Table 31. Illumina Solid Tumor Testing Total Revenue (USD Million) (2017-2018)
Table 32. Illumina SWOT Analysis
Table 33. Illumina Solid Tumor Testing Product and Solutions
Table 34. Illumina Solid Tumor Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 36. Thermo Fisher Scientific Solid Tumor Testing Major Business
Table 37. Thermo Fisher Scientific Solid Tumor Testing Total Revenue (USD Million) (2017-2018)
Table 38. Thermo Fisher Scientific SWOT Analysis
Table 39. Thermo Fisher Scientific Solid Tumor Testing Product and Solutions
Table 40. Thermo Fisher Scientific Solid Tumor Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Solid Tumor Testing Revenue (Million USD) by Players (2015-2020)
Table 42. Global Solid Tumor Testing Revenue Share by Players (2015-2020)
Table 43. Global Solid Tumor Testing Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Solid Tumor Testing Revenue Market Share by Regions (2015-2020)
Table 45. North America Solid Tumor Testing Revenue by Countries (2015-2020)
Table 46. North America Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Table 47. Europe Solid Tumor Testing Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Solid Tumor Testing Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Solid Tumor Testing Revenue by Countries (2015-2020)
Table 50. South America Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Solid Tumor Testing Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Table 53. Global Solid Tumor Testing Revenue (Million USD) by Type (2015-2020)
Table 54. Global Solid Tumor Testing Revenue Share by Type (2015-2020)
Table 55. Global Solid Tumor Testing Revenue Forecast by Type (2021-2025)
Table 56. Global Solid Tumor Testing Revenue by Application (2015-2020)
Table 57. Global Solid Tumor Testing Revenue Share by Application (2015-2020)
Table 58. Global Solid Tumor Testing Revenue Forecast by Application (2021-2025)
Table 59. Global Solid Tumor Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Solid Tumor Testing Picture
Figure 2. Global Solid Tumor Testing Revenue Market Share by Type in 2019
Figure 3. Conventional Testing Picture
Figure 4. Non-Conventional Testing Picture
Figure 5. Solid Tumor Testing Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Academic and Research Institutes Picture
Figure 9. Global Solid Tumor Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Solid Tumor Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Solid Tumor Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Solid Tumor Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Solid Tumor Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Solid Tumor Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Solid Tumor Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Solid Tumor Testing Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Solid Tumor Testing Revenue Market Share in 2019
Figure 18. Global Top 10 Players Solid Tumor Testing Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Solid Tumor Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Solid Tumor Testing Revenue Market Share by Regions (2015-2020)
Figure 22. Global Solid Tumor Testing Revenue Market Share by Regions in 2018
Figure 23. North America Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 24. Europe Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 26. South America Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 28. North America Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Figure 29. North America Solid Tumor Testing Revenue Market Share by Countries in 2019
Figure 30. USA Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 31. Canada Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 33. Europe Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Solid Tumor Testing Revenue Market Share by Countries in 2019
Figure 35. Germany Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 36. UK Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 37. France Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 38. Russia Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 39. Italy Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Solid Tumor Testing Revenue Market Share by Countries in 2019
Figure 42. China Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 43. Japan Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 44. Korea Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 45. India Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 47. South America Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Figure 48. South America Solid Tumor Testing Revenue Market Share by Countries in 2019
Figure 49. Brazil Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Solid Tumor Testing Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Solid Tumor Testing Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 54. UAE Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Solid Tumor Testing Revenue and Growth Rate (2015-2020)
Figure 57. Global Solid Tumor Testing Revenue Share by Type (2015-2020)
Figure 58. Global Solid Tumor Testing Revenue Share by Type in 2019
Figure 59. Global Solid Tumor Testing Market Share Forecast by Type (2021-2025)
Figure 60. Global Conventional Testing Revenue Growth Rate (2015-2020)
Figure 61. Global Non-Conventional Testing Revenue Growth Rate (2015-2020)
Figure 62. Global Solid Tumor Testing Revenue Share by Application (2015-2020)
Figure 63. Global Solid Tumor Testing Revenue Share by Application in 2019
Figure 64. Global Solid Tumor Testing Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 67. Global Academic and Research Institutes Revenue Growth Rate (2015-2020)
Figure 68. Global Solid Tumor Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Solid Tumor Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Solid Tumor Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Solid Tumor Testing Revenue Market Forecast (2021-2025)
Figure 72. Europe Solid Tumor Testing Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Solid Tumor Testing Revenue Market Forecast (2021-2025)
Figure 74. South America Solid Tumor Testing Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Solid Tumor Testing Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel